IASLC-LCRF Team Science Research Grant on Advancing Therapies Towards Curing Oncogenic-Driven Lung Cancers
Forecasted
This grant funds collaborative research teams advancing therapies to cure oncogene-driven lung cancers, supporting integrated projects through the International Association for the Study of Lung Cancer.
Funder: International Association for the Study of Lung Cancer
Due Dates (Anticipated): October 2026 (Letter of Intent) | January 2027 (Full Application)
Funding Amounts: Up to $2.5 million USD total over four years, awarded to a collaborative team science program.
Summary: Supports integrated, multi-project research teams advancing therapies to cure oncogene-driven lung cancer.
Key Information: This is a forecasted opportunity; all dates are projected and subject to change.
Description
This large-scale team science grant, jointly offered by the International Association for the Study of Lung Cancer (IASLC) and the Lung Cancer Research Foundation (LCRF), aims to accelerate progress toward curing oncogene-driven lung cancers. The award supports collaborative research teams proposing closely integrated projects that collectively address the ambitious goal of curing these cancers. The program is designed to fund coordinated research efforts that exceed the capabilities of single investigators or isolated projects, fostering innovation and synergy across disciplines.
